Flexible Work, Better Balance
The Global Program Lead (GPL) will serve as the point of accountability for two first-in-class protein degraders in lymphoma with registrational ambition. The program includes ongoing Phase 3 studies and the opportunity to redefine the lymphoma treatment paradigm. The GPL is accountable for leading the Global Program Teams and orchestrating the design and execution of a global integrated program strategy from candidate nomination through drug development to successful launch and commercialization.
Technical & Functional Responsibilities